Key result
Surgical excision of cardiac myxomas resulted in a 10% hospital mortality rate, with no recurrences observed among survivors over a mean follow-up of 76.4 months.
Why the study?
Does surgical excision of cardiac myxomas improve survival and prevent recurrence in patients with cardiac myxoma?
Observational (n=50)
Does surgical excision of cardiac myxomas improve survival and prevent recurrence in patients with cardiac myxoma?
Surgical excision of cardiac myxomas is curative, providing excellent long-term survival and symptomatic improvement with no observed recurrences.
No takes yet. Share an insight, caveat, or question.
Supports excision for myxomas with no recurrences in survivors; leaves open broader outcome validation beyond case reports.
L Lukács (1997) conducted an observational in Cardiac myxoma (n=50). Surgical excision was evaluated on Hospital mortality rate. Surgical excision of cardiac myxomas resulted in a 10% hospital mortality rate, with no recurrences observed among survivors over a mean follow-up of 76.4 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: